Comments on "Vitamin Pharmacogenomics: New Insight into Individual Differences in Diseases and Drug Responses".
作者信息
Greenfield Tom
机构信息
International College of Generative Medicine, Canterbury, Kent CT1 1BL, United Kingdom.
出版信息
Genomics Proteomics Bioinformatics. 2017 Dec;15(6):405-406. doi: 10.1016/j.gpb.2017.09.001. Epub 2017 Oct 7.
Abstract
摘要
相似文献
1
Comments on "Vitamin Pharmacogenomics: New Insight into Individual Differences in Diseases and Drug Responses".
Genomics Proteomics Bioinformatics. 2017 Dec;15(6):405-406. doi: 10.1016/j.gpb.2017.09.001. Epub 2017 Oct 7.
2
Author's Reply: Comments on "Vitamin Pharmacogenomics: New Insight into Individual Differences in Diseases and Drug Responses".
Genomics Proteomics Bioinformatics. 2017 Dec;15(6):407. doi: 10.1016/j.gpb.2017.09.002. Epub 2017 Oct 7.
3
Vitamin Pharmacogenomics: New Insight into Individual Differences in Diseases and Drug Responses.
Genomics Proteomics Bioinformatics. 2017 Apr;15(2):94-100. doi: 10.1016/j.gpb.2016.10.005. Epub 2017 Apr 1.
4
One size fits one: pharmacogenetics in gastroenterology.
Clin Gastroenterol Hepatol. 2014 Apr;12(4):565-70. doi: 10.1016/j.cgh.2014.01.035. Epub 2014 Jan 30.
5
Pharmacogenetics and pharmacogenomics as new tools to optimise cancer chemotherapy.
J Chemother. 2004 Nov;16 Suppl 4:22-4. doi: 10.1179/joc.2004.16.Supplement-1.22.
6
Pharmacogenomics in admixed populations.
Trends Pharmacol Sci. 2005 Apr;26(4):196-201. doi: 10.1016/j.tips.2005.02.008.
7
Pharmacogenomics: bench to bedside.
Nat Rev Drug Discov. 2004 Sep;3(9):739-48. doi: 10.1038/nrd1497.
8
Pharmacogenetics and pharmacogenomics as tools in cancer therapy.
Drug Metab Pers Ther. 2016 Mar;31(1):25-34. doi: 10.1515/dmpt-2015-0042.
9
Pharmacogenomics and pancreatic cancer treatment. Optimizing current therapy and individualizing future therapy.
JOP. 2008 May 8;9(3):251-66.
10
Applying pharmacogenomics to enhance the use of biomarkers for drug effect and drug safety.
Trends Pharmacol Sci. 2006 Sep;27(9):498-502. doi: 10.1016/j.tips.2006.07.005. Epub 2006 Jul 27.
本文引用的文献
1
Vitamin Pharmacogenomics: New Insight into Individual Differences in Diseases and Drug Responses.
Genomics Proteomics Bioinformatics. 2017 Apr;15(2):94-100. doi: 10.1016/j.gpb.2016.10.005. Epub 2017 Apr 1.
2
GWAS identifies population-specific new regulatory variants in FUT6 associated with plasma B12 concentrations in Indians.
Hum Mol Genet. 2017 Jul 1;26(13):2551-2564. doi: 10.1093/hmg/ddx071.
3
Gastric intrinsic factor deficiency with combined GIF heterozygous mutations and FUT2 secretor variant.
Biochimie. 2013 May;95(5):995-1001. doi: 10.1016/j.biochi.2013.01.022. Epub 2013 Feb 8.
4
Common variant in FUT2 gene is associated with levels of vitamin B(12) in Indian population.
Gene. 2013 Feb 15;515(1):224-8. doi: 10.1016/j.gene.2012.11.021. Epub 2012 Nov 29.
5
Helicobacter pylori serologic status has no influence on the association between fucosyltransferase 2 polymorphism (FUT2 461 G->A) and vitamin B-12 in Europe and West Africa.
Am J Clin Nutr. 2012 Feb;95(2):514-21. doi: 10.3945/ajcn.111.016410. Epub 2012 Jan 11.
6
Genome-wide significant predictors of metabolites in the one-carbon metabolism pathway.
Hum Mol Genet. 2009 Dec 1;18(23):4677-87. doi: 10.1093/hmg/ddp428. Epub 2009 Sep 10.
7
Common variants of FUT2 are associated with plasma vitamin B12 levels.
Nat Genet. 2008 Oct;40(10):1160-2. doi: 10.1038/ng.210. Epub 2008 Sep 7.
8
Sequence and expression of a candidate for the human Secretor blood group alpha(1,2)fucosyltransferase gene (FUT2). Homozygosity for an enzyme-inactivating nonsense mutation commonly correlates with the non-secretor phenotype.
J Biol Chem. 1995 Mar 3;270(9):4640-9. doi: 10.1074/jbc.270.9.4640.
Zotero 插件